The company specializes in developing and supplying innovative solutions for the regenerative medicine industry, including cGMP growth factors, culture media, recombinant and human proteins, novel cryopreservation media, delivery technologies, and bioengineered scaffolds. Akron's unique business model emphasizes flexibility, quality, and unparalleled service, providing raw materials and components for superior research and product development in stem cell and cell culture products, as well as cGMP tools and technologies for the cell therapy industry.